Objective: Zea m1 is one of the most common aeroallergens, causing allergy. This pollen allergen, present in maize, is responsible for type I hypersensitivity reaction. Despite having available X ray crystal structure of this pollen allergen, no definite vaccine has been developed for allergic disorder in humans. Method: In our present study, an epitope-based peptide vaccine against Zea m 1 pollen allergen, using a combination of B cell and T cell epitope predictions, followed by molecular docking and molecular dynamics simulation methods are carried out. Here, protein sequences of homologous pollen allergens of Zea m1 are collected and conserved regions present in them are investigated. Result: From the identified region of the allergenic protein, the peptide sequence KVPPG-PNITTNY and the sequence AEWKPMKLSM are considered as the most potential B cell and T cell epitopes respectively. Furthermore, this predicted T cell epitope AEWKPMKLSM interacted with MHC allelic protein HLA-B*44:02 with the lowest IC 50 value (7.94 nM). This epitope perfectly fitted into the epitope binding groove of alpha helix of MHC I molecule with lowest energy weighted score -620.0, showing stability in MHC binding.
INTRODUCTION
Allergic diseases are one of the most prevalent health problem along the world. More than 25% of the world's population is affected by type I hypersensitivity reaction. Among the other causes of allergic reactions, pollen allergens are considered as potential source of hypersensitivity reaction. Aeroallergens, the most common causes of nasobronchial allergy due to contact with grass and tree pollen allergens. 1 Grass pollen allergens from Zea mays are responsible for the allergic reaction among susceptible individuals. 2 In the medical science different types of medicines e.g. mast cell stabilizers etc. are used to treat allergic reactions. But several other alternative methods e.g. hypo allergen production, allergenspecific immunotherapy, conversion of allergens into vaccines with reduced allergenic activity 3 etc. are recommended in post genomic era.
Zea m 1 has been crystalized and identified as group I pollen allergen from maize. 4 By the process of molecular allergen characterization, allergy vaccines can be achieved as recombinant allergens, peptides and genes of allergens. B-cell epitope mapping is a promising method to identifying the main antigenic determinants or epitopes of microorganisms. Epitopebased vaccines have outstanding approach compared to the conventional ones since they are specific in nature, able to avoid unwanted immune reactions, having power to generate long lasting immunity, and are practically cheaper in price. Epitope based peptide vaccine design method is to develop vaccines for various disorders, for example, malaria, 5 common krait toxin 6 and zika virus.
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MATERIALS AND METHODS
Retrieval of Zea m 1 and identification of conserved regions among homologous pollen allergen of Zea m 1
The protein sequence and 3D structure of Zea m1 allergenic protein were obtained from UniProt knowledgebase. 8 In SDAP allergen database, 9 FAO/WHO Allergenicity Rules based on sequence homology for full FASTA alignment for fasta sequence of 2HCZ showed 50 sequences of allergens with an E score higher than 0.01. Alignment was made with FAST 3.45. 10 Different protein sequences of pollen allergens were selected and retrieved from Swiss-prot 11 in FASTA format. To find conserved region, retrieved sequences were aligned using Muscle tool 3.8.31 12 where k-mer clustering was used. In the next step a tree was constructed by the method known as progressive alignment. The evolutionary divergence analysis for all 50 pollen allergens were completed by forming a phylogenetic tree using Phy ML 3.1/3.0 aLRT software. 13 
Potential T-cell epitope Identification
CD+8 T-cell epitope prediction
Linear T-cell epitopes for MHC-I binding for Zea m 1 allergenic protein are identified by consensus methods using Artificial neural network (ANN) 14 and Stabilized matrix method (SMM) 15 from tools for MHC -I binding prediction methods of Immune Epitope Database (IEDB) (www. iedb.org). 16 SMM algorithm of MHC-1 binding, transporter of antigenic peptides (TAP) transport efficiency and proteasomal cleavage efficiency are considered to determine the IC 50 values for processing prediction of epitopes by MHC-I molecules. 17 On the basis of low IC 50 values, 5 best epitopes bind with specific MHC-1 molecules are designated for further evaluation.
CD+4 T-cell epitope prediction
CD4+ T-cell receptor responses against concerned allergen are done by using Peptide binding to MHC class II molecules software using MHC II binding prediction tool in IEDB analysis resource, including a consensus approach which combines NN-align, SMM-align 18 and Combinatorial library methods. For this prediction we chose thirty HLA class II alleles from the reference set. For the predicted T-cell epitopes with low percentile rank are identified and their IC50 values for respective alleles are determined by SMM-align method. 18 
Potential B cell epitope identification
The B cell epitope is the part of the antigenic polypeptide chain which interacts with immunoglobulin molecules. Various physico-chemical properties e.g. hydrophilicity, flexibility, accessibility, turns, exposed surface, polarity and antigenic propensity of polypeptides chains have been associated with the location of continuous epitopes of antigenic proteins. 19 Thus, different tools from IEDB (www.iedb.org), including the classical propensity scale methods such as Kolaskar and Tongaonkar antigenicity scale, 20 Emini surface accessibility prediction, 21 Parker hydrophilicity prediction, 22 Karplus and Schulz flexibilty prediction, 23 Bepipred linear epitope prediction 24 and Chou and Fashman beta turn prediction tool 25 are used to predict B cell epitopes of Zea m 1. From the prediction results most common findings are considered a probable B cell epitope.
Analysis of population coverage
Population coverage for identified T cell epitopes is assessed for world population with the help of IEDB population coverage calculation tool. 26 This tool computes the fraction of individuals predicted to reply to a given set of epitopes with recognized MHC restrictions.
Docking study of B cell and T cell epitopes
For docking studies, the T cell epitope AEWKPMKLSM and B cell epitope KVPPGPNITTNY are selected and subjected to PEP-FOLD server 27 for 3D structure formation. To identify the molecular interactions with specific HLA protein and immunoglobulin E for respective epitopes, docking studies are performed with ClusPro 2.2 web server. 28 Cluster scores for lowest binding energy prediction are calculated. Modified PDB ID 1M6O for HLA-B*44:02 is used as allelic protein for docking study of T cell epitope. Similarly, 3D structure (PDB ID 4J4P) for immunoglobulin E molecule is used as receptor molecule for B cell epitope docking analysis.
Molecular simulation study of predicted T cell epitope with HLA allelic protein
The entire molecular dynamics simulation study for HLA-epitope protein complex is accomplished with MDWeb i.e. Molecular dynamics on Web 29 a web server. A solvent box is added to minimize the energy of the system after equilibrating it using NAMD force field method. Then the solvent is heated to 300K and after that protein restraints are lowered. A multiple time step algorithm along with a simulation time step 2.0 fs has been chosen. Molecular dynamics simulations of 5ns long is performed at constant temperature and pressure. The MD trajectories are drawn for 0.1 ps for analysis. The trajectories are generated from the simulation study are evaluated for the stability by various parameters viz, B factor (atomic fluctuation), RMSD, radius of gyration.
RESULT
Homologous pollen allergenic sequences retrieval and identification of conserved regions
From SDAP allergen database, 9 50 homologous allergens are identified using amino acid sequence of pollen allergen Zea m 1 as shown in Table 1 , since sequences with E values < 0.01 are almost always homologous in nature. All 50 protein sequences are retrieved from SwissProt 11 and aligned to identify conserved sequences with varying length using Muscle tool 3.8.31 12 in Table 2 .
A phylogenetic tree illustrating the evolutionary relationship among the 50 homologous allergens is depicted in Figure 1 .
CD8+ T-cell epitope identification
IEDB recommended prediction method for MHC-I binding with CD8+ T cell epitope suggest that the lower the percentile rank the epitope would be good binder. The predicted percentile rank with consensus method and IC 50 values with SMM method 15 are shown in Table 3 .
CD4+ T-cell epitope identification
Peptide binding cleft in MHC -II molecule is wider than that of MHC-I molecule. So, 15mer epitopes are predicted by consensus method. IC 50 values for predicted epitopes along with their MHC II alleles are displayed in Table 4 .
Analysis of Population coverage
IEDB population coverage tool 26 is used to calculate the population coverage of the predicted epitopes. The result for combined method with both class I and II MHC restriction for the whole world and Indian population with the selected MHC I and MHC II alleles is shown in Table 5 .
Prediction of B cell epitopes
Predicted scores for Emini surface accessibility, 21 Parker hydrophilicity, 22 Karplus and Schulz flexibility 23 and Chou and Fashman beta turn 25 along with their threshold values are exhibited in Table 6 . Prediction scores of above-mentioned parameters for each residue of peptide 28 
KVPPGPNITTNYN
40 reveals that this short stretch of antigenic protein can act as linear B cell epitope. Kolaskar and Tongaonkar antigenicity prediction scores 20 for each residue of that peptide chain confirms KVPPG as antigenic determinant of Zea m 1 allergenic protein. Residue N at position 40 is not present in sequence of conserved region. The T cell epitope   209   AEWKPMKLSW 218 is selected on the basis of its interactions with large number of alleles and lowest IC 50 value with HLA-B*44:02 MHC I allele. Similarly, 28 
Docking study of B cell and T cell epitopes
KVPPGPNITTNY
39 is designated as most probable B cell epitope which is also present in conserved region of pollen allergen Zea m 1. Docking studies are performed with these two epitopes with human HLA-B*44:02 MHC I molecule and immunoglobulin protein E respectively.
Molecular simulation study of predicted T cell epitope with HLA allelic protein
The complex structure of predicted T cell epitope with HLA allelic protein is subjected for molecular dynamics study. The 5ns MD simulation of HLA-epitope (HLA-B*44:02-AEWKPMKLSW) complex is carried out using NAMD force field, following the energy minimization protocol. The stability of the HLA protein with T cell epitope complex with the help of B factor and RMSD value are calculated and shown in Figure 4a and remained stable in the range of 1.0 Å to 1.2 Å. As seen in Figure 4a , highest B factor (atomic fluctuation) is observed for SER residue at the position of 342 in HLA-epitope complex, while lowest B factor observed for TRP 237. Similarly, the 342 residue also shows the highest RMSD of 0.915458 Å. The plot for radius of gyration of the HLA-epitope complex shows its compactness. The radius of gyration value during 5ns simulation slightly varies from 26.1 to 26.6. This means that the HLA-epitope complex is stably folded during simulation study. Hence, all analyses lead to the conclusion that AEWKPMKLSM is the most suitable T cell epitope for peptide-based vaccine design.
Potential T-cell epitope identification
DISCUSSION
In present days, the primary focus of vaccine development mainly depends on peptide-based vaccine design. Here, computational method-based epitope mapping is very efficient method for drug design where the total process is safe, rapid and cost effective. This study incorporates various immunoinformatic, molecular docking and molecular simulation techniques to identify potential epitopes present in Zea m 1 pollen allergen. First of all, fifty homologous allergens from SDAP allergen database 9 are identified and aligned to identify conserved sequences present in them.
Moreover, a phylogenetic analysis shows a closed evolutionary relationship among the homologous allergens. So, it is believed that targeting Zea m 1 pollen allergen for vaccine design against pollinosis, could provide cross reactive reaction data for all homologous allergens. At the beginning five potent 10mer CD8 + T cell epitopes for MHC-I binding have been predicted from IEDB recommended prediction method. The percentile rank and IC 50 values with SMM method, covering all 12 MHC class I supertypes are also predicted. The five most potent epitopes are represented in Table 3 21 Parker hydrophilicity, 22 Karplus and Schulz flexibility, 23 Chou and Fashman beta turn 25 for each residue of peptide KVPPG-PNITTNY starting from 28 position and ending in 39 positions of Zea m 1 protein sequence, reveals that this is the most potential B cell epitope present in this pollen allergen. Furthermore, Kolarskar and Tangaonkar antigenicity prediction scores, confirm our prediction. Lastly, this predicted B cell epitope sequence is also conserved among the fifty homologous allergenic protein sequences. We also validate our predicted B cell epitope and T cell epitope by molecular docking analysis. In Docking study, the B cell epitope KVPPGPNITTNY with protein human immunoglobulin E, forms a stable complex. Similarly, the most suitable T cell epitope is perfectly fitted with the epitope binding groove of a helix of HLA-B*44:02 MHC-I molecule. 
